Skip to main content
. Author manuscript; available in PMC: 2019 Nov 11.
Published in final edited form as: Anticancer Res. 2018 Nov;38(11):6361–6366. doi: 10.21873/anticanres.12994

Figure 3.

Figure 3.

Podocalyxin immunohistochemistry in prostate cancer. A: High-grade prostate cancer. B: Low-grade prostate cancer. C: Benign epithelium (left) and low-grade prostate cancer (right). Original magnification ×400.